{
    "organizations": [],
    "uuid": "1abcc8e6c63b6d474dc95c0a56a2efa5011aca16",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-malin-corp-says-poseida-reports-po/brief-malin-corp-says-poseida-reports-positive-initial-clinical-data-idUSASO0003ET",
    "ord_in_thread": 0,
    "title": "BRIEF-Malin Corp Says Poseida Reports Positive Initial Clinical Data",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - Malin Corporation plc:\n* POSEIDA REPORTS POSITIVE INITIAL CLINICAL DATA * HIGHLY ENCOURAGING DATA REPORTED AT AACR ANNUAL MEETING 2018, BY ONE OF ITS INVESTEE COMPANIES, POSEIDA THERAPEUTICS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-18T16:21:00.000+03:00",
    "crawled": "2018-04-19T14:48:14.073+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "malin",
        "corporation",
        "plc",
        "poseida",
        "report",
        "positive",
        "initial",
        "clinical",
        "data",
        "highly",
        "encouraging",
        "data",
        "reported",
        "aacr",
        "annual",
        "meeting",
        "one",
        "investee",
        "company",
        "poseida",
        "therapeutic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}